Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4242695)

Published in Neuropsychiatr Dis Treat on November 19, 2014

Authors

Brittany B Dennis1, M Constantine Samaan2, Monica Bawor3, James Paul4, Carolyn Plater5, Guillaume Pare1, Andrew Worster6, Michael Varenbut5, Jeff Daiter5, David C Marsh7, Dipika Desai8, Lehana Thabane9, Zainab Samaan10

Author Affiliations

1: Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
2: Department of Pediatrics, Division of Pediatric Endocrinology, McMaster University, Hamilton, ON, Canada.
3: McMaster Integrative Neuroscience Discovery and Study Program, McMaster University, Hamilton, ON, Canada.
4: Department of Anesthesia, McMaster University, Hamilton, ON, Canada.
5: Ontario Addiction Treatment Centres, Richmond Hill, ON, Canada.
6: Department of Medicine, Hamilton General Hospital, Hamilton, ON, Canada.
7: Ontario Addiction Treatment Centres, Richmond Hill, ON, Canada ; Northern Ontario School of Medicine, Sudbury, ON, Canada.
8: Population Genomics Program, Chanchlani Research Centre, McMaster University, Hamilton, ON, Canada.
9: Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada ; Centre for Evaluation of Medicine, Hamilton, ON, Canada ; System Linked Research Unit, Hamilton, ON, Canada.
10: Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada ; Population Genomics Program, Chanchlani Research Centre, McMaster University, Hamilton, ON, Canada ; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.

Articles cited by this

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52

Mechanisms underlying inflammation in neurodegeneration. Cell (2010) 7.66

The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci (2007) 5.38

Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA (1998) 5.20

Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA (2003) 4.25

Role of the immune system in chronic pain. Nat Rev Neurosci (2005) 4.10

Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci (2005) 4.01

Glial activation: a driving force for pathological pain. Trends Neurosci (2001) 3.98

Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev (2002) 2.75

Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull (2011) 2.22

Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun (2008) 1.92

Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend (2004) 1.71

IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci U S A (2009) 1.57

Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain (2005) 1.48

Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine (2000) 1.46

Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm (2013) 1.43

Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug Alcohol Depend (2005) 1.38

Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol (2011) 1.36

Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain (2014) 1.33

Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy (2003) 1.31

Inflammation and central nervous system Lyme disease. Neurobiol Dis (2009) 1.26

Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction (2007) 1.24

Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm Res (2007) 1.21

Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment. Am J Addict (2009) 1.19

Counselors' Experiences Treating Methadone-maintained Patients with Chronic Pain: A Needs Assessment Study. J Addict Med (2008) 1.08

Comparable efficacy of contingency management for cocaine dependence among African American, Hispanic, and White methadone maintenance clients. Psychol Addict Behav (2009) 0.97

Genome-wide analysis of pain-, nerve- and neurotrophin -related gene expression in the degenerating human annulus. Mol Pain (2012) 0.91

Mortality among methadone maintenance clients in China: a six-year cohort study. PLoS One (2013) 0.89

Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study. Neuropsychiatr Dis Treat (2014) 0.89

Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus study). PLoS One (2011) 0.87

Cytokine evaluation in individuals with low back pain using discographic lavage. Spine J (2010) 0.87

Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations? Clin Chem Lab Med (2008) 0.84